![PDCD_Report_Final-1](https://i0.wp.com/www.umdf.org/wp-content/uploads/2023/12/PDCD_Report_Final-1.png?resize=1080%2C244&ssl=1)
On September 8, 2023, the United Mitochondrial Disease Foundation co-hosted a Patient-led Listening Session with the U.S. Food & Drug Administration for Pyruvate Dehydrogenase Complex Deficiency (PDCD) with fellow patient advocacy groups MitoAction, Hope for PDCD, and The Elizabeth Watt PDCD Research Fund.